Results
Dr Lal PathLabs Q2 Net Profit Rises 27% YoY
Board approved Q2 FY27 standalone net profit of ₹1,797 million, up 27% YoY, with revenue at ₹8,660 million.
Declared second interim dividend of ₹5 per share with record date set for November 11, 2026.
